Disclosure Panels Details Page
Ovarian Cancer Panel - Disclosures as of 04/09/2014
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Ronald Alvarez MD | Merrimack Morphotek Inc. Pfizer Inc. |
Amgen Inc. | None | None | ✔ |
| Deborah Armstrong MD | Astellas Pharma US, Inc. Genentech, Inc. MedImmune Inc. Merrimack Morphotek Inc. |
Morphotek Inc. | None | None | ✔ |
| Jennifer Burns BS | None | None | None | None | - |
| Lee-May Chen MD | None | None | None | None | ✔ |
| Larry Copeland MD | None | None | None | None | - |
| Marta Ann Crispens MD | Merrimack Pharmaceuticals Novartis Pharmaceuticals Corporation Spirogen |
None | None | None | ✔ |
| Mary Dwyer MS | None | None | None | None | - |
| Fayna Ferkle PharmD | None | None | None | None | - |
| Lauren Gallagher | None | None | None | None | - |
| David Gershenson MD | AstraZeneca Pharmaceuticals LP Genentech, Inc. GSK National Cancer Institute Pfizer Inc. |
None | None | Elsevier|Informa|Johnson & Johnson|Merck & Co., Inc.|National Cancer Institute|Proctor and Gamble|Up to Date | ✔ |
| Heidi Gray MD | Abbott Laboratories Prima Biomed |
Prima Biomed | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Ardeshir Hakam MD | None | None | None | None | ✔ |
| Laura Havrilesky MD | None | None | None | None | - |
| Miranda Hughes PhD | None | None | None | None | - |
| Carolyn Johnston MD | None | None | MPRO | american cancer society document reviewer|american cancer society-great lakes division|michigan cancer consortium | ✔ |
| Shashikant Lele MD | None | None | None | None | ✔ |
| Lainie Martin MD | None | None | Clovis Oncology | None | ✔ |
| Ursula Matulonis MD | AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Eli Lilly and Company Genentech, Inc. GSK Merck & Co., Inc. |
Clovis Pathway Therapeutics |
Clovis Merck & Co., Inc. Tesaro |
None | ✔ |
| Joan McClure MS | None | None | None | None | - |
| Robert Morgan MD, FACP | NIH-CTEP | None | None | None | ✔ |
| David O'Malley MD | Genentech, Inc. | None | None | None | ✔ |
| Richard Penson MD, MRCP | Amgen Inc. AstraZeneca Pharmaceuticals LP Eisai Inc. Eli Lilly and Company Endocyte Inc. Genentech, Inc. ImClone Systems Incorporated |
AstraZeneca Pharmaceuticals LP BioMarin Clovis Oncology Genentech, Inc. Lifecore Biomedical |
None | None | ✔ |
| Steven Plaxe MD, FACOG, FACS | Amgen Inc. azaya endocyte Millennium Pharmaceuticals, Inc. Pfizer Inc. |
None | insys | Abbott Laboratories|Bristol Myers Squibb|Pfizer Inc. | ✔ |
| Matthew Powell MD | Bristol Myers Squibb Eisai Inc. |
AnorMED Inc. | None | None | ✔ |
| Steven Remmenga MD | None | None | None | None | ✔ |
| Paul Sabbatini MD | Prim Biomed | None | None | None | ✔ |
| Joseph Santoso MD | None | Janssen Pharmaceutica Products, LP lab cor vermillion |
None | None | - |
| Monique Spillman MD, PhD | GOG | None | None | None | - |
| Nelson Teng MD, PhD | NA | NA | NA | NA | - |
| Theresa Werner MD | None | None | None | None | ✔ |